GROW vs WST · P/E 244, rev $14.4M vs P/E 35, rev $1.72B
US Global Investors Inc (GROW) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
US Global Investors Inc (GROW) is a asset management company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported GROW revenue for 2026-06-30 was $14.4M. Net income was $3.1M. Revenue was up 32.8% from 2025-06-30 to 2026-06-30. GROW currently screens at market cap $32.3M and trailing P/E 244.0.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
GROW currently screens at market cap $32.3M and trailing P/E 244.0. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the GROW and WST stock pages for the full models.
Not investment advice.